Home Current issue Ahead of print Search About us Editorial board Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2017  |  Volume : 36  |  Issue : 4  |  Page : 368-371

Value of pharmacologic thromboprophylaxis for prevention of thromboembolic complications in bariatric surgery


1 Department of General Surgery, Faculty of Medicine, Cairo University, Cairo, Egypt
2 Deapartment of Radiodiagnosis, Faculty of Medicine, Cairo University, Cairo, Egypt

Correspondence Address:
Hany A Balamoun
Department of General Surgery, Faculty of Medicine, Cairo University, Cairo - 11562
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ejs.ejs_50_17

Rights and Permissions

Objective The objective of this study was to assess safety and efficacy of pharmacologic thromboprophylaxis in morbidly obese patients undergoing bariatric surgery for prevention of silent deep vein thrombosis (DVT). Patients and methods This prospective study included 50 morbidly obese patients scheduled for primary one-stage laparoscopic bariatric surgery randomly allocated into one of two treatment groups according to the method of thromboprophylaxis. Group M (n=25) was subjected to mechanical prophylaxis with bilateral graduated compression stockings. Group MC (n=25) was subjected to mechanical plus pharmacologic prophylaxis using 40 mg of the low-molecular-weight heparin enoxaparin subcutaneously, 12 h before surgery, and postoperatively daily for 2 weeks. Bilateral lower limb venous duplex was done to detect silent DVT (the primary outcome measure), before discharge and after 2 weeks. Results Three patients developed silent DVT (6%); all of them were among group M (P=0.235, relative risk: 0.47, 95% confidence interval: 0.35–0.64). There was no significant difference between patients with DVT and those without DVT regarding age, BMI, operative time, comorbidities, or type of surgery. No bleeding complications were recorded in the two studied groups. Conclusion Perioperative low-molecular-weight heparin extending for 2 weeks postoperatively combined with graduated compression stockings is safe and effective for the prevention of silent DVT following laparoscopic bariatric surgery.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed29    
    Printed0    
    Emailed0    
    PDF Downloaded8    
    Comments [Add]    

Recommend this journal